Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Benzinga_recent_news01-28

Nuwellis Inc (NASDAQ:NUWE) stock is on fire. Shares of the tiny medical device maker surged more than 100% in pre-market trading Tuesday and were still up around 85% by 10 AM ET in early trading, as ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2606736672?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/27/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-01-28 00:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606736672","market":"us","top_or_hot":-1,"title":"Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare","media":"Benzinga_recent_news","content":"<div>\n<p>Nuwellis Inc (NASDAQ:NUWE) stock is on fire. Shares of the tiny medical device maker surged more than 100% in pre-market trading Tuesday and were still up around 85% by 10 AM ET in early trading, as ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/01/50162742/nuwellis-stock-surges-100-as-2-microcap-beats-big-pharma-in-infant-healthcare\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-28 00:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/01/50162742/nuwellis-stock-surges-100-as-2-microcap-beats-big-pharma-in-infant-healthcare><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nuwellis Inc (NASDAQ:NUWE) stock is on fire. Shares of the tiny medical device maker surged more than 100% in pre-market trading Tuesday and were still up around 85% by 10 AM ET in early trading, as ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/01/50162742/nuwellis-stock-surges-100-as-2-microcap-beats-big-pharma-in-infant-healthcare\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBI","symbol_name":"SPDR S&P Biotech ETF","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/50162742/nuwellis-stock-surges-100-as-2-microcap-beats-big-pharma-in-infant-healthcare","article_id":"2606736672","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/27/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/50162742/nuwellis-stock-surges-100-as-2-microcap-beats-big-pharma-in-infant-healthcare","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606736672","pubTimestamp":1769530440,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Nuwellis Inc (NASDAQ:NUWE) saw its stock soar over 100% in pre-market trading amid a boardroom shakeup and a new pediatric USPTO patent.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBI":"SPDR S&P Biotech ETF","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","NUWE":"Nuwellis, Inc.","BK4082":"医疗保健设备","BK4581":"高盛持仓","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","LABU":"三倍做多标普生物-Direxion","HCSG":"Healthcare Svcs Group Inc","BK4137":"综合支持服务","BK4585":"ETF&股票定投概念","BK4588":"碎股","XLV":"健康照护类股ETF-SPDR"},"translate_title":"Nuwellis股价飙升100%，2美元微型股在婴儿医疗保健领域击败大型制药公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"HCSG":1.5,"LABU":0.6,"NUWE":1,"XBI":0.6},"content_text":"Nuwellis Inc (NASDAQ:NUWE) stock is on fire. Shares of the tiny medical device maker surged more than 100% in pre-market trading Tuesday and were still up around 85% by 10 AM ET in early trading, as investors piled into a rare microcap healthcare narrative: patents, a boardroom reset, and a niche Big Pharma largely ignored.\nFor a company with a market value near $2 million, that's a powerful cocktail.\nLate last week, Nuwellis disclosed a sweeping board shakeup, with three long-serving directors stepping down and two new directors with experience scaling medical technology companies joining the board. \nThe company also streamlined its board, a move often seen when companies are preparing for faster execution, restructuring, or strategic interest.\nFor microcap traders, board changes often signal that something bigger may be brewing.\nThe stock is also riding momentum from early January, when the U.S. Patent and Trademark Office issued a new patent for the company's Vivian™ Pediatric CRRT System, strengthening its intellectual property moat in infant blood filtration.\nPediatric renal therapy is a tiny but high-margin niche with significant regulatory barriers, which is why patents matter. In healthcare, niche IP can be the difference between obscurity and acquisition interest.\nWith a razor-thin float and limited liquidity, Nuwellis is classic momentum fuel. The stock's triple-digit pre-market surge and sustained gains in early trading reflect retail traders chasing the patent-and-boardroom narrative.\nWhether this turns into a long-term business story or another microcap spike remains to be seen. But the pitch is clear: a $2 microcap may have quietly built a defensible corner of infant healthcare that much larger players overlooked—and the market is suddenly paying attention.\nNUWE Price Action: Nuwellis shares were up 71.86% at $3.69 at the time of publication on Tuesday, according to Benzinga Pro data.\nPhoto: jittawit21/Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606736672","isCrawlerRequest":true}